140 related articles for article (PubMed ID: 3688024)
1. Linear growth response to exogenous growth hormone in Prader-Willi syndrome.
Lee PD; Wilson DM; Rountree L; Hintz RL; Rosenfeld RG
Am J Med Genet; 1987 Dec; 28(4):865-71. PubMed ID: 3688024
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database).
Lindgren AC; Lindberg A
Horm Res; 2008; 70(3):182-7. PubMed ID: 18663319
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
Craig ME; Cowell CT; Larsson P; Zipf WB; Reiter EO; Albertsson Wikland K; Ranke MB; Price DA;
Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957
[TBL] [Abstract][Full Text] [Related]
4. Prader-Willi syndrome: how does growth hormone affect body composition and physical function?
Carrel AL; Allen DB
J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1445-51. PubMed ID: 11837498
[TBL] [Abstract][Full Text] [Related]
5. Prader-Labhart-Willi syndrome: auxological response to a conventional dose of growth hormone in patients with classical growth hormone deficiency.
Schmidt H; Bechtold S; Schwarz HP
Eur J Med Res; 2000 Jul; 5(7):307-10. PubMed ID: 10903191
[TBL] [Abstract][Full Text] [Related]
6. The Prader-Willi syndrome: a study of 40 patients and a review of the literature.
Bray GA; Dahms WT; Swerdloff RS; Fiser RH; Atkinson RL; Carrel RE
Medicine (Baltimore); 1983 Mar; 62(2):59-80. PubMed ID: 6338343
[TBL] [Abstract][Full Text] [Related]
7. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
Myers SE; Carrel AL; Whitman BY; Allen DB
J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone treatment of patients with Prader-Willi syndrome. Swedish Growth Hormone Advisory Group.
Ritzén EM; Lindgren AC; Hagenäs L; Marcus C; Müller J; Blichfeldt S
J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():345-9. PubMed ID: 10698600
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
Festen DA; de Lind van Wijngaarden R; van Eekelen M; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884
[TBL] [Abstract][Full Text] [Related]
10. Analysis of NREM sleep in children with Prader-Willi syndrome and the effect of growth hormone treatment.
Verrillo E; Bruni O; Franco P; Ferri R; Thiriez G; Pavone M; Petrone A; Paglietti MG; Crinò A; Cutrera R
Sleep Med; 2009 Jun; 10(6):646-50. PubMed ID: 19027358
[TBL] [Abstract][Full Text] [Related]
11. Five-years growth hormone (GH) treatment in adults with Prader-Willi syndrome.
Höybye C
Acta Paediatr; 2007 Mar; 96(3):410-3. PubMed ID: 17407467
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone therapy for Prader-Willi syndrome: a critical appraisal.
Allen DB; Carrel AL
J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1297-306. PubMed ID: 15506076
[TBL] [Abstract][Full Text] [Related]
13. Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndrome.
Grugni G; Marzullo P; Ragusa L; Sartorio A; Trifirò G; Liuzzi A; Crinò A;
Clin Endocrinol (Oxf); 2006 Oct; 65(4):492-9. PubMed ID: 16984242
[TBL] [Abstract][Full Text] [Related]
14. Early manifestations of Prader-Willi syndrome: influence of growth hormone.
Eiholzer U; Schlumpf M; Nordmann Y; l'Allemand D
J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1441-4. PubMed ID: 11837497
[TBL] [Abstract][Full Text] [Related]
15. Body composition during GH treatment in Prader-Labhardt-Willi syndrome.
Bosio L; Beccaria L; Benzi F; Sanzari A; Chiumello G
J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():351-3. PubMed ID: 10698601
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone induced lipolysis during short- and long-term administration in adult Prader-Willi patients.
Höybye C; Hilding A; Marcus C; Thorén M
Growth Horm IGF Res; 2005 Dec; 15(6):411-5. PubMed ID: 16230042
[TBL] [Abstract][Full Text] [Related]
17. [Prader-Labhart-Willi syndrome].
Fesseler WH; Bierich JR
Monatsschr Kinderheilkd; 1983 Dec; 131(12):844-7. PubMed ID: 6664356
[TBL] [Abstract][Full Text] [Related]
18. Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome.
Fillion M; Deal C; Van Vliet G
J Pediatr; 2009 Feb; 154(2):230-3. PubMed ID: 18814886
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of growth hormone therapy on patients with Prader-Willi syndrome.
Sipilä I; Sintonen H; Hietanen H; Apajasalo M; Alanne S; Viita AM; Leinonen E
Acta Paediatr; 2010 Nov; 99(11):1712-8. PubMed ID: 20545932
[TBL] [Abstract][Full Text] [Related]
20. [Growth hormone therapy in childhood. Growth hormone therapy in small children without growth hormone deficiency].
Butenandt O
Fortschr Med; 1996 Jun; 114(16):201-4. PubMed ID: 8767930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
